32.39 cases / 100,000 people double vaccinated vs 31.93 / 100k of the unvaccinated.
https://covid-19.ontario.ca/data?fbclid=IwAR2pRUq9GN9EEoDTm0...
The vaccines don't seem to confer any lasting difference.
32.39 cases / 100,000 people double vaccinated vs 31.93 / 100k of the unvaccinated.
https://covid-19.ontario.ca/data?fbclid=IwAR2pRUq9GN9EEoDTm0...
The vaccines don't seem to confer any lasting difference.
One concern with observational studies: people who choose vaccination don't behave exactly the same as people who don't. They may assume more risks out of perceived safety. They may also be more likely to test or seek medical care. This is why, at a minimum, you need case control to start to believe the conclusions.
In any case, we have actual case control studies showing mRNA vaccine efficacy against illness and particularly against severe illness from Omicron. They disagree on the amounts, and in some cases the numbers are not thrilling (30%), but there's no studies so far implying no efficacy.
The study we're discussing here concludes its abstract with: "These data support the notion that, provided high neutralization capacity is elicited by vaccination/boosting approaches, reasonable effectiveness against Omicron may be maintained."
I think you could give out 2 doses of a strong laxative and show it statistically protects sick people against covid too. If you take out the weakest, the rest will seem to do better.
Edit: Disclaimer at the top of the page says technical difficulty.
The effect is caused by the age data ending in mid-October, before the spike we're looking at in mid-December. So, the age-segregated data couldn't show that spike at all.
Why would we expect vaccine derived coronavirus-19 immunity to be substantially longer than natural other-coronavirus immunity, which we know to be months, not years.
That is, we know of many vaccines where the protection from vaccination is greater than the protection from prior infection. It looks like that is true of COVID vaccines, both by observational / case control data and from data comparing antibody neutralizing titers between convalescent plasma and vaccinated individuals.. e.g. https://cdn.jamanetwork.com/ama/content_public/journal/jama/...
For any given patient--- who knows. There could be one person somewhere who'd get no benefit from vaccination and a huge benefit from prior infection. We can only know about the superiority of vaccination to prior infection in aggregate, but the effect is real.